Director/PDMR Shareholding

Tristel

26/03/2025 10:30

RNS Number : 3167C

Tristel PLC

26 March 2025

 

Tristel plc

("Tristel" or the "Company")

 

Director/PDMR Shareholding

CEO buys shares

               

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that Matthew Sassone, Chief Executive Officer of the Company, has purchased 3,500 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 310 pence per Ordinary Share.

 

As a result, Matthew Sassone's beneficial interest in the Company is 3,500 Ordinary Shares, representing 0.007 per cent. of the total issued share capital.

 

 

 

For further information please contact:     

 

Tristel plc
Via Walbrook PR
Matt Sassone, Chief Executive Officer
www.investors.tristel.com
Liz Dixon, Chief Financial Officer
Walbrook PR Ltd
Tel: 020 7933 8780 ortristel@walbrookpr.com
Paul McManus
Mob: 07980 541 893
Lianne Applegarth
Mob: 07584 391303
Cavendish Capital Markets Limited
Tel: 020 7220 0500
Geoff Nash / Camilla Hume / Trisyia Jamaludin (Corporate Finance)
Sunila de Silva (ECM)
Louise Talbot (Sales)


 

About Tristel plc

Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries.

 

The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit: https://tristel.com

  

 

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014 which forms part of UK Law by virtue of the European Union (Withdrawal) Act 2018.

 

 

1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Matthew Sassone
2.
Reason for the Notification
a)
Position/status
CEO
b)
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Tristel plc
b)
LEI
2138009DZ4LH9CZGF662
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Ordinary shares of 1p each
Identification code
GB00B07RVT99
b)
Nature of the transaction
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
310 pence, 3,500 shares
d)
Aggregated information:
· Aggregated volume
· Price
See above
e)
Date of the transaction
26 March 2025
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHZZGZFGVFGKZM